<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="204720">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00000251</url>
  </required_header>
  <id_info>
    <org_study_id>NIDA-08391-3</org_study_id>
    <secondary_id>R01DA008391</secondary_id>
    <secondary_id>R01-08391-3</secondary_id>
    <nct_id>NCT00000251</nct_id>
  </id_info>
  <brief_title>Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3</brief_title>
  <official_title>Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct experiments to examine subjective and reinforcing
      effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug
      abusers and preference procedures will be used to assess reinforcing effects. To evaluate
      the acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide
      combinations in healthy volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 1994</start_date>
  <completion_date type="Actual">January 1996</completion_date>
  <primary_completion_date type="Actual">January 1996</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Logical reasoning test</measure>
    <time_frame>15 &amp; 30 min inhalation and 5, 30, &amp; 60 min post inhalation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Free recall memory test</measure>
    <time_frame>15 &amp; 30 min inhalation and 5, 30, &amp; 60 min post inhalation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Auditory reaction time</measure>
    <time_frame>15 &amp; 30 min inhalation and 5,30 &amp; 60 min post inhalation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Digit symbol substitution test</measure>
    <time_frame>2,15 &amp; 30 min inhalation and 5,30 &amp; 60 min post inhalation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Opioid-Related Disorders</condition>
  <condition>Substance-Related Disorders</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects inhale 100% oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30% N2O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects inhale 30% N2O</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.2% isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects inhale 0.2% isoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.4% isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects inhale 0.4% isoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.2% isoflurane + 30% N2O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will inhale a combination of 0.2% isoflurane and 30% N2O</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.4% isoflurane + 30% N2O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will inhale a combination of 0.4% isoflurane and 30% N2O</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30% N2O</intervention_name>
    <arm_group_label>30% N2O</arm_group_label>
    <arm_group_label>0.2% isoflurane + 30% N2O</arm_group_label>
    <arm_group_label>0.4% isoflurane + 30% N2O</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.2% isoflurane</intervention_name>
    <arm_group_label>0.2% isoflurane</arm_group_label>
    <arm_group_label>0.2% isoflurane + 30% N2O</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.4% isoflurane</intervention_name>
    <arm_group_label>0.4% isoflurane</arm_group_label>
    <arm_group_label>0.4% isoflurane + 30% N2O</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>100% oxygen</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Please contact site for information.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>32 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Zacny, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago, Anesthesia &amp; Critical Care</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Zacny JP, Yajnik S, Lichtor JL, Klafta JM, Young CJ, Thapar P, Rupani G, Coalson DW, Apfelbaum JL. The acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide combinations on cognitive and psychomotor performance in healthy volunteers. Anesth Analg. 1996 Jan;82(1):153-7.</citation>
    <PMID>8712393</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 30, 2015</lastchanged_date>
  <firstreceived_date>September 20, 1999</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nitrous oxide</keyword>
  <keyword>isoflurane</keyword>
  <keyword>subjective effects</keyword>
  <keyword>psychomotor</keyword>
  <keyword>healthy volunteer</keyword>
  <keyword>drug interaction</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
